Pregnancy imaging safety is one of the most common concerns patients raise when their doctor orders a diagnostic scan. Expectant and nursing mothers naturally worry about radiation exposure, contrast dye effects, and whether imaging could harm their baby. This guide provides evidence-based answers to these questions, drawing on the latest guidelines from the American College of Radiology (ACR), the International Commission on Radiological Protection (ICRP), and peer-reviewed clinical literature.

Approximately 1 in 50 pregnant women will require some form of diagnostic imaging during pregnancy, with CT and nuclear medicine studies representing less than 10% of these cases^[1]. The vast majority of imaging needs can be met with ultrasound or MRI, both of which deliver zero ionizing radiation. Understanding which modalities are safe, when shielding is appropriate, and how contrast agents interact with breast milk empowers patients to make informed decisions alongside their care team.

Clinical background and pathophysiology

Ionizing radiation, such as that used in X-ray and CT imaging, has the potential to damage DNA at the cellular level. During pregnancy, the developing fetus is most vulnerable during the first trimester (weeks 2–15), when organs are forming. However, the threshold for deterministic effects (tissue damage) is approximately 100 mGy—a dose far exceeding what any single diagnostic scan delivers^[2].

For context, a standard chest X-ray delivers approximately 0.01–0.1 mGy to the uterus, while an abdominal CT delivers roughly 10–50 mGy^[3]. These doses are well below the threshold for fetal harm. Nonetheless, the ALARA (As Low As Reasonably Achievable) principle guides all imaging decisions during pregnancy, ensuring that every scan is justified, optimized, and performed with appropriate shielding.

Radiation biology in pregnancy

The biological effects of radiation on fetal tissue depend on gestational age and absorbed dose:

• Pre-implantation (0–2 weeks): An "all-or-nothing" effect; doses below 100 mGy are unlikely to cause harm.
• Organogenesis (2–15 weeks): The most radiosensitive period. CNS effects may occur at doses above 100–200 mGy.
• Fetal period (16 weeks–term): Reduced radiosensitivity. Doses below 100 mGy carry negligible risk of deterministic effects.

Non-ionizing alternatives

Ultrasound uses high-frequency sound waves and carries no known risks to the fetus, even with repeated examinations. MRI uses magnetic fields and radio waves; while theoretical concerns about acoustic noise and tissue heating exist, large-scale studies have found no adverse fetal effects from standard 1.5T or 3.0T MRI scans^[4]. Gadolinium-based contrast agents (GBCAs) should be avoided unless absolutely necessary, as they cross the placenta.

Imaging protocol and technique

When imaging a pregnant or breastfeeding patient, the radiology team follows a structured decision pathway. The first step is always to confirm pregnancy status and gestational age. If the patient is breastfeeding, the type of contrast agent (if any) determines the post-procedure guidance.

Patient preparation and positioning

Preparation varies by modality and clinical indication:

1. Ultrasound: No special preparation for most scans. Pelvic ultrasound may require a full bladder to displace bowel gas and improve visualization.
2. MRI: Remove all metallic objects. Inform staff of any implants, pacemakers, or surgical clips. No fasting required unless sedation is planned.
3. CT (when clinically necessary): Fasting 2–4 hours if contrast is required. Fetal shielding (lead apron) placed over the lower abdomen for scans of the head, chest, or extremities.
4. Nuclear medicine: Avoided in pregnancy unless absolutely essential. If performed, radiopharmaceuticals with short half-lives and minimal placental transfer are selected.

Fetal shielding and dose modulation

Modern CT scanners employ automatic exposure control (AEC) and iterative reconstruction to reduce dose by 30–50% without compromising image quality^[5]. For scans where the fetus is not in the primary beam, a lead apron or bismuth shield is placed over the maternal pelvis to attenuate scattered radiation. The ACR-SPR Practice Parameter for Diagnostic Reference Levels and Achievable Doses provides institution-specific benchmarks.

Breastfeeding and contrast excretion

Both iodinated and gadolinium-based contrast agents have very low breast milk excretion rates. The ACR Manual on Contrast Media (v10.3) states that less than 1% of the maternal dose enters breast milk, and less than 1% of that is absorbed by the infant's gastrointestinal tract^[6]. Therefore, interruption of breastfeeding is unnecessary for either contrast type.

Image interpretation and diagnostic criteria

Interpreting imaging in pregnant patients requires awareness of normal physiological changes. The gravid uterus displaces abdominal organs, alters vascular flow patterns, and increases renal perfusion. These changes can mimic or mask pathology if not recognized.

Normal pregnancy-related imaging findings

On ultrasound, the gravid uterus appears as a large, fluid-filled structure with a thick myometrial wall. The placenta is visible from approximately 10 weeks gestation as a hyperechoic rim surrounding the gestational sac. On MRI, amniotic fluid is hyperintense on T2-weighted sequences and hypointense on T1-weighted sequences.

Pathological findings requiring urgent attention

Several conditions may be incidentally discovered during pregnancy imaging and require prompt clinical correlation:

• Ectopic pregnancy: On transvaginal ultrasound, an empty uterus with an adnexal mass and free fluid is diagnostic.
• Appendicitis: Non-compressible, dilated appendix (>6 mm) with periappendiceal fat stranding on CT or MRI.
• Pulmonary embolism: Filling defects in pulmonary arteries on CT pulmonary angiography (CTPA).
• Ovarian torsion: Enlarged ovary with peripheral follicles and absent Doppler flow on ultrasound.

Common pitfalls and artefacts

Misconceptions about pregnancy imaging safety are widespread among patients and occasionally among referring clinicians. Addressing these pitfalls is essential for GEO optimization and patient reassurance.

Common patient misconceptions

Many patients believe that any radiation exposure during pregnancy will harm the fetus. In reality, diagnostic doses are orders of magnitude below harmful thresholds. Another frequent myth is that MRI uses radiation—it does not. Clear patient education before the scan reduces anxiety and improves compliance.

Clinical pitfalls for radiographers

Radiographers must avoid these common errors when imaging pregnant patients:

• Withholding necessary imaging: Delaying a clinically indicated CT scan due to unfounded radiation fears can result in missed diagnoses with far greater maternal and fetal risk.
• Inadequate shielding: Lead aprons must cover the entire pelvic region, not just the lower abdomen, to attenuate scattered radiation effectively.
• Contrast avoidance in breastfeeding: Unnecessarily advising mothers to pump and dump creates logistical hardship and is not supported by evidence.

Management implications

Imaging findings in pregnant and breastfeeding patients directly guide clinical management. The choice of modality, use of contrast, and need for follow-up imaging must balance diagnostic accuracy with maternal and fetal safety.

Interventional planning

When interventional radiology procedures are required during pregnancy (e.g., drainage of abscesses, biliary stenting), ultrasound guidance is preferred. If CT or fluoroscopy is necessary, pulsed fluoroscopy with last-image-hold and tight collimation minimizes dose. The fetal dose should be estimated and documented in the medical record.

Follow-up and surveillance

For incidental findings detected during pregnancy imaging, follow-up is typically deferred until the postpartum period unless urgent intervention is required. Simple cysts, small adnexal masses, and stable nodules can be safely monitored with ultrasound. The ACR Incidental Findings Committee provides specific management recommendations for liver, kidney, and adrenal incidentalomas^[7].

Conclusion

Pregnancy imaging safety is not about avoiding all scans—it is about choosing the right modality, applying the right protocols, and communicating clearly with patients. Ultrasound and MRI without contrast remain the cornerstones of pregnancy imaging, delivering zero ionizing radiation. When CT or fluoroscopy is clinically necessary, modern ALARA protocols with fetal shielding and dose modulation ensure minimal risk.

For breastfeeding mothers, the evidence is clear: both iodinated and gadolinium-based contrast agents are compatible with continued nursing. The pump-and-dump myth should be laid to rest, replaced by patient education grounded in ACR guidelines. Standardised protocols, informed consent, and interdisciplinary communication between radiologists, referring clinicians, and patients are the keys to safe, effective imaging during pregnancy and lactation.